Search Results for: Schizophrenia

1632 interactions found:

Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
ST3GAL1 and GSTA1 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 glutathione S-transferase alpha 1
  • Keratan sulfate/keratin metabolism
  • MPS I - Hurler syndrome
  • MPS IX - Natowicz syndrome
  • Glycosaminoglycan metabolism
  • Defective MGAT2 causes MGAT2-CDG (CDG-2a)
  • O-linked glycosylation
  • Defective CHST14 causes EDS, musculocontractural type
  • Myoclonic epilepsy of Lafora
  • MPS IIID - Sanfilippo syndrome D
  • Defective CHST6 causes MCDC1
  • Glycogen storage diseases
  • Defective ALG2 causes ALG2-CDG (CDG-1i)
  • Keratan sulfate biosynthesis
  • Diseases associated with glycosaminoglycan metabolism
  • Mucopolysaccharidoses
  • Defective ALG3 causes ALG3-CDG (CDG-1d)
  • Post-translational protein modification
  • Defective EXT2 causes exostoses 2
  • Termination of O-glycan biosynthesis
  • Synthesis of substrates in N-glycan biosythesis
  • Asparagine N-linked glycosylation
  • MPS IV - Morquio syndrome A
  • Sialic acid metabolism
  • Defective MPDU1 causes MPDU1-CDG (CDG-1f)
  • Metabolism of carbohydrates
  • O-linked glycosylation of mucins
  • Diseases associated with N-glycosylation of proteins
  • MPS VI - Maroteaux-Lamy syndrome
  • MPS IIIB - Sanfilippo syndrome B
  • Diseases of glycosylation
  • Defective B4GALT7 causes EDS, progeroid type
  • Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
  • Defective SLC26A2 causes chondrodysplasias
  • Defective ALG1 causes ALG1-CDG (CDG-1k)
  • Defective MOGS causes MOGS-CDG (CDG-2b)
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein
  • Defective ALG9 causes ALG9-CDG (CDG-1l)
  • Defective PAPSS2 causes SEMD-PA
  • Defective MAN1B1 causes MRT15
  • MPS IIIA - Sanfilippo syndrome A
  • Defective ALG11 causes ALG11-CDG (CDG-1p)
  • MPS IIIC - Sanfilippo syndrome C
  • Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
  • MPS II - Hunter syndrome
  • Defective CHST3 causes SEDCJD
  • Defective B3GAT3 causes JDSSDHD
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Defective EXT1 causes exostoses 1, TRPS2 and CHDS
  • Defective RFT1 causes RFT1-CDG (CDG-1n)
  • Defective ALG6 causes ALG6-CDG (CDG-1c)
  • Defective ALG8 causes ALG8-CDG (CDG-1h)
  • Defective CHSY1 causes TPBS
  • MPS IV - Morquio syndrome B
  • Defective ALG12 causes ALG12-CDG (CDG-1g)
  • MPS VII - Sly syndrome
  • Defective OPLAH causes 5-oxoprolinase deficiency (OPLAHD)
  • Defective AHCY causes Hypermethioninemia with S-adenosylhomocysteine hydrolase deficiency (HMAHCHD)
  • Defective TPMT causes Thiopurine S-methyltransferase deficiency (TPMT deficiency)
  • Defective MAT1A causes Methionine adenosyltransferase deficiency (MATD)
  • Defective UGT1A4 causes hyperbilirubinemia
  • Glutathione conjugation
  • Metabolic disorders of biological oxidation enzymes
  • Phase II conjugation
  • Defective UGT1A1 causes hyperbilirubinemia
  • Defective SLC35D1 causes Schneckenbecken dysplasia (SCHBCKD)
  • Biological oxidations
  • Defective GCLC causes Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency (HAGGSD)
  • Defective GGT1 causes Glutathionuria (GLUTH)
  • Defective GSS causes Glutathione synthetase deficiency (GSS deficiency)
  • Glutathione
  • S-Hydroxycysteine
  • 2-Hydroxyethyl Disulfide
  • N-(4-Aminobutanoyl)-S-(4-Methoxybenzyl)-L-Cysteinylglycine
  • Glutathione Sulfonic Acid
  • S-Benzyl-Glutathione
  • S-Hexylglutathione
GNB1 and HDAC4 guanine nucleotide binding protein (G protein), beta polypeptide 1 histone deacetylase 4
  • Signaling by GPCR
  • Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
  • ADP signalling through P2Y purinoceptor 1
  • Integration of energy metabolism
  • G alpha (s) signalling events
  • Activation of GABAB receptors
  • Glucagon-type ligand receptors
  • G beta:gamma signalling through PLC beta
  • Signaling by Wnt
  • Metabolic disorders of biological oxidation enzymes
  • G protein gated Potassium channels
  • Olfactory Signaling Pathway
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Thromboxane signalling through TP receptor
  • G alpha (z) signalling events
  • G alpha (i) signalling events
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • ADP signalling through P2Y purinoceptor 12
  • Glucagon signaling in metabolic regulation
  • Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits
  • Inwardly rectifying K+ channels
  • G-protein beta:gamma signalling
  • Opioid Signalling
  • Activation of Kainate Receptors upon glutamate binding
  • Diseases associated with visual transduction
  • Aquaporin-mediated transport
  • Adrenaline,noradrenaline inhibits insulin secretion
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Platelet homeostasis
  • Platelet activation, signaling and aggregation
  • Transmission across Chemical Synapses
  • G alpha (q) signalling events
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signal amplification
  • Potassium Channels
  • Activation of the phototransduction cascade
  • Inactivation, recovery and regulation of the phototransduction cascade
  • G beta:gamma signalling through PI3Kgamma
  • The phototransduction cascade
  • G alpha (12/13) signalling events
  • Class B/2 (Secretin family receptors)
  • Prostacyclin signalling through prostacyclin receptor
  • GABA B receptor activation
  • GABA receptor activation
  • Activation of G protein gated Potassium channels
  • Vasopressin regulates renal water homeostasis via Aquaporins
  • Regulation of insulin secretion
  • GPCR ligand binding
  • beta-catenin independent WNT signaling
  • Thrombin signalling through proteinase activated receptors (PARs)
  • Presynaptic function of Kainate receptors
  • Visual phototransduction
  • Ca2+ pathway
  • G-protein activation
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • Signaling by NOTCH
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Signaling by NOTCH1
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • Signaling by NOTCH1 in Cancer
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • FBXW7 Mutants and NOTCH1 in Cancer
GNB1 and CACNA1C guanine nucleotide binding protein (G protein), beta polypeptide 1 calcium channel, voltage-dependent, L type, alpha 1C subunit
  • Signaling by GPCR
  • Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
  • ADP signalling through P2Y purinoceptor 1
  • Integration of energy metabolism
  • G alpha (s) signalling events
  • Activation of GABAB receptors
  • Glucagon-type ligand receptors
  • G beta:gamma signalling through PLC beta
  • Signaling by Wnt
  • Metabolic disorders of biological oxidation enzymes
  • G protein gated Potassium channels
  • Olfactory Signaling Pathway
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Thromboxane signalling through TP receptor
  • G alpha (z) signalling events
  • G alpha (i) signalling events
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • ADP signalling through P2Y purinoceptor 12
  • Glucagon signaling in metabolic regulation
  • Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits
  • Inwardly rectifying K+ channels
  • G-protein beta:gamma signalling
  • Opioid Signalling
  • Activation of Kainate Receptors upon glutamate binding
  • Diseases associated with visual transduction
  • Aquaporin-mediated transport
  • Adrenaline,noradrenaline inhibits insulin secretion
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Platelet homeostasis
  • Platelet activation, signaling and aggregation
  • Transmission across Chemical Synapses
  • G alpha (q) signalling events
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signal amplification
  • Potassium Channels
  • Activation of the phototransduction cascade
  • Inactivation, recovery and regulation of the phototransduction cascade
  • G beta:gamma signalling through PI3Kgamma
  • The phototransduction cascade
  • G alpha (12/13) signalling events
  • Class B/2 (Secretin family receptors)
  • Prostacyclin signalling through prostacyclin receptor
  • GABA B receptor activation
  • GABA receptor activation
  • Activation of G protein gated Potassium channels
  • Vasopressin regulates renal water homeostasis via Aquaporins
  • Regulation of insulin secretion
  • GPCR ligand binding
  • beta-catenin independent WNT signaling
  • Thrombin signalling through proteinase activated receptors (PARs)
  • Presynaptic function of Kainate receptors
  • Visual phototransduction
  • Ca2+ pathway
  • G-protein activation
  • NCAM1 interactions
  • Axon guidance
  • Integration of energy metabolism
  • Regulation of insulin secretion
  • NCAM signaling for neurite out-growth
  • Adrenaline,noradrenaline inhibits insulin secretion
  • Isradipine
  • Ibutilide
  • Amlodipine
  • Nimodipine
  • Nisoldipine
  • Cinnarizine
  • Nicardipine
  • Magnesium Sulfate
  • Verapamil
  • Felodipine
  • Nitrendipine
  • Nifedipine
  • Calcium
  • Mibefradil
  • Dronedarone
  • Clevidipine
  • Nilvadipine
  • Drotaverine
GNB1 and DISC1 guanine nucleotide binding protein (G protein), beta polypeptide 1 disrupted in schizophrenia 1
  • Signaling by GPCR
  • Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
  • ADP signalling through P2Y purinoceptor 1
  • Integration of energy metabolism
  • G alpha (s) signalling events
  • Activation of GABAB receptors
  • Glucagon-type ligand receptors
  • G beta:gamma signalling through PLC beta
  • Signaling by Wnt
  • Metabolic disorders of biological oxidation enzymes
  • G protein gated Potassium channels
  • Olfactory Signaling Pathway
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Thromboxane signalling through TP receptor
  • G alpha (z) signalling events
  • G alpha (i) signalling events
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • ADP signalling through P2Y purinoceptor 12
  • Glucagon signaling in metabolic regulation
  • Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits
  • Inwardly rectifying K+ channels
  • G-protein beta:gamma signalling
  • Opioid Signalling
  • Activation of Kainate Receptors upon glutamate binding
  • Diseases associated with visual transduction
  • Aquaporin-mediated transport
  • Adrenaline,noradrenaline inhibits insulin secretion
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Platelet homeostasis
  • Platelet activation, signaling and aggregation
  • Transmission across Chemical Synapses
  • G alpha (q) signalling events
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signal amplification
  • Potassium Channels
  • Activation of the phototransduction cascade
  • Inactivation, recovery and regulation of the phototransduction cascade
  • G beta:gamma signalling through PI3Kgamma
  • The phototransduction cascade
  • G alpha (12/13) signalling events
  • Class B/2 (Secretin family receptors)
  • Prostacyclin signalling through prostacyclin receptor
  • GABA B receptor activation
  • GABA receptor activation
  • Activation of G protein gated Potassium channels
  • Vasopressin regulates renal water homeostasis via Aquaporins
  • Regulation of insulin secretion
  • GPCR ligand binding
  • beta-catenin independent WNT signaling
  • Thrombin signalling through proteinase activated receptors (PARs)
  • Presynaptic function of Kainate receptors
  • Visual phototransduction
  • Ca2+ pathway
  • G-protein activation
PLCG1 and GRIN2A phospholipase C, gamma 1 glutamate receptor, ionotropic, N-methyl D-aspartate 2A
  • Signaling by the B Cell Receptor (BCR)
  • Phospholipase C-mediated cascade
  • Signaling by FGFR in disease
  • FCERI mediated MAPK activation
  • Signaling by EGFRvIII in Cancer
  • PLCG1 events in ERBB2 signaling
  • DAP12 signaling
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • Synthesis of IP3 and IP4 in the cytosol
  • Signaling by FGFR1 mutants
  • Role of phospholipids in phagocytosis
  • Fcgamma receptor (FCGR) dependent phagocytosis
  • Signaling by PDGF
  • DAP12 interactions
  • Inositol phosphate metabolism
  • Antiviral mechanism by IFN-stimulated genes
  • EGFR interacts with phospholipase C-gamma
  • Signaling by ERBB2
  • Signaling by EGFR
  • TCR signaling
  • Signaling by VEGF
  • Downstream signal transduction
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • Signaling by FGFR mutants
  • Frs2-mediated activation
  • Adaptive Immune System
  • Signalling to ERKs
  • Prolonged ERK activation events
  • Axon guidance
  • DAG and IP3 signaling
  • VEGFA-VEGFR2 Pathway
  • VEGFR2 mediated cell proliferation
  • Downstream signaling of activated FGFR
  • Netrin-1 signaling
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Innate Immune System
  • Signalling by NGF
  • Generation of second messenger molecules
  • ISG15 antiviral mechanism
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Signaling by FGFR
  • PECAM1 interactions
  • Cell surface interactions at the vascular wall
  • Role of second messengers in netrin-1 signaling
  • PLC-gamma1 signalling
  • FCERI mediated Ca+2 mobilization
  • Constitutive Signaling by EGFRvIII
  • Signaling by FGFR1 fusion mutants
  • Activation of NMDA receptor upon glutamate binding and postsynaptic events
  • CREB phosphorylation through the activation of CaMKII
  • CREB phosphorylation through the activation of Ras
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • Unblocking of NMDA receptor, glutamate binding and activation
  • Ras activation uopn Ca2+ infux through NMDA receptor
  • Post NMDA receptor activation events
  • Transmission across Chemical Synapses
  • L-Glutamic Acid
  • Glycine
  • Meperidine
  • Felbamate
  • Memantine
  • Halothane
  • Tenocyclidine
PLCG1 and NTRK3 phospholipase C, gamma 1 neurotrophic tyrosine kinase, receptor, type 3
  • Signaling by the B Cell Receptor (BCR)
  • Phospholipase C-mediated cascade
  • Signaling by FGFR in disease
  • FCERI mediated MAPK activation
  • Signaling by EGFRvIII in Cancer
  • PLCG1 events in ERBB2 signaling
  • DAP12 signaling
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • Synthesis of IP3 and IP4 in the cytosol
  • Signaling by FGFR1 mutants
  • Role of phospholipids in phagocytosis
  • Fcgamma receptor (FCGR) dependent phagocytosis
  • Signaling by PDGF
  • DAP12 interactions
  • Inositol phosphate metabolism
  • Antiviral mechanism by IFN-stimulated genes
  • EGFR interacts with phospholipase C-gamma
  • Signaling by ERBB2
  • Signaling by EGFR
  • TCR signaling
  • Signaling by VEGF
  • Downstream signal transduction
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • Signaling by FGFR mutants
  • Frs2-mediated activation
  • Adaptive Immune System
  • Signalling to ERKs
  • Prolonged ERK activation events
  • Axon guidance
  • DAG and IP3 signaling
  • VEGFA-VEGFR2 Pathway
  • VEGFR2 mediated cell proliferation
  • Downstream signaling of activated FGFR
  • Netrin-1 signaling
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Innate Immune System
  • Signalling by NGF
  • Generation of second messenger molecules
  • ISG15 antiviral mechanism
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Signaling by FGFR
  • PECAM1 interactions
  • Cell surface interactions at the vascular wall
  • Role of second messengers in netrin-1 signaling
  • PLC-gamma1 signalling
  • FCERI mediated Ca+2 mobilization
  • Constitutive Signaling by EGFRvIII
  • Signaling by FGFR1 fusion mutants
RXRA and NFKB1 retinoid X receptor, alpha nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
  • Bile acid and bile salt metabolism
  • Metabolism of lipids and lipoproteins
  • Nuclear Receptor transcription pathway
  • Metabolic disorders of biological oxidation enzymes
  • Defective CYP2U1 causes Spastic paraplegia 56, autosomal recessive (SPG56)
  • Generic Transcription Pathway
  • Endogenous sterols
  • Synthesis of bile acids and bile salts
  • Orphan transporters
  • Defective FMO3 causes Trimethylaminuria (TMAU)
  • Signaling by Retinoic Acid
  • Recycling of bile acids and salts
  • Defective CYP26B1 causes Radiohumeral fusions with other skeletal and craniofacial anomalies (RHFCA)
  • Defective CYP17A1 causes Adrenal hyperplasia 5 (AH5)
  • Defective CYP19A1 causes Aromatase excess syndrome (AEXS)
  • Regulation of pyruvate dehydrogenase (PDH) complex
  • Pyruvate metabolism
  • Synthesis of bile acids and bile salts via 27-hydroxycholesterol
  • Defective MAOA causes Brunner syndrome (BRUNS)
  • Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3)
  • Activation of gene expression by SREBF (SREBP)
  • The citric acid (TCA) cycle and respiratory electron transport
  • Transcriptional activation of mitochondrial biogenesis
  • PPARA activates gene expression
  • Defective CYP2R1 causes Rickets vitamin D-dependent 1B (VDDR1B)
  • Organelle biogenesis and maintenance
  • Import of palmitoyl-CoA into the mitochondrial matrix
  • Pyruvate metabolism and Citric Acid (TCA) cycle
  • Defective CYP27B1 causes Rickets vitamin D-dependent 1A (VDDR1A)
  • Phase 1 - Functionalization of compounds
  • RORA activates circadian gene expression
  • Regulation of cholesterol biosynthesis by SREBP (SREBF)
  • Defective CYP26C1 causes Focal facial dermal dysplasia 4 (FFDD4)
  • Cytochrome P450 - arranged by substrate type
  • Transcriptional regulation of white adipocyte differentiation
  • Biological oxidations
  • Defective TBXAS1 causes Ghosal hematodiaphyseal dysplasia (GHDD)
  • Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)
  • Fatty acid, triacylglycerol, and ketone body metabolism
  • Defective CYP27A1 causes Cerebrotendinous xanthomatosis (CTX)
  • Defective CYP11B1 causes Adrenal hyperplasia 4 (AH4)
  • REV-ERBA represses gene expression
  • Defective CYP1B1 causes Glaucoma
  • Mitochondrial biogenesis
  • Defective CYP7B1 causes Spastic paraplegia 5A, autosomal recessive (SPG5A) and Congenital bile acid synthesis defect 3 (CBAS3)
  • Defective CYP4F22 causes Ichthyosis, congenital, autosomal recessive 5 (ARCI5)
  • Defective CYP24A1 causes Hypercalcemia, infantile (HCAI)
  • Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol
  • Defective CYP11B2 causes Corticosterone methyloxidase 1 deficiency (CMO-1 deficiency)
  • YAP1- and WWTR1 (TAZ)-stimulated gene expression
  • Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
  • BMAL1:CLOCK,NPAS2 activates circadian gene expression
  • Signaling by the B Cell Receptor (BCR)
  • NF-kB is activated and signals survival
  • Downstream TCR signaling
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Cellular Senescence
  • RIP-mediated NFkB activation via ZBP1
  • Toll Like Receptor TLR6:TLR2 Cascade
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • Activated TLR4 signalling
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Downstream signaling events of B Cell Receptor (BCR)
  • FCERI mediated NF-kB activation
  • MyD88 cascade initiated on plasma membrane
  • Toll Like Receptor 5 (TLR5) Cascade
  • ZBP1(DAI) mediated induction of type I IFNs
  • p75NTR signals via NF-kB
  • Transcriptional regulation of white adipocyte differentiation
  • MyD88 dependent cascade initiated on endosome
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • MyD88:Mal cascade initiated on plasma membrane
  • Toll Like Receptor 9 (TLR9) Cascade
  • Innate Immune System
  • Regulated proteolysis of p75NTR
  • Signalling by NGF
  • TRIF-mediated TLR3/TLR4 signaling
  • Cytosolic sensors of pathogen-associated DNA
  • Senescence-Associated Secretory Phenotype (SASP)
  • Cytokine Signaling in Immune system
  • p75 NTR receptor-mediated signalling
  • MyD88-independent cascade
  • Toll Like Receptor 2 (TLR2) Cascade
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Signaling by Interleukins
  • TCR signaling
  • Toll-Like Receptors Cascades
  • Toll Like Receptor 10 (TLR10) Cascade
  • Interleukin-1 processing
  • Toll Like Receptor 3 (TLR3) Cascade
  • Toll Like Receptor 4 (TLR4) Cascade
  • Activation of NF-kappaB in B cells
  • Fc epsilon receptor (FCERI) signaling
  • TRAF6 mediated NF-kB activation
  • Interleukin-1 signaling
  • Adaptive Immune System
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Adapalene
  • Bexarotene
  • Acitretin
  • Alitretinoin
  • Etodolac
  • Etretinate
  • (5BETA)-PREGNANE-3,20-DIONE
  • 2-chloro-5-nitro-N-phenylbenzamide
  • 1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE
  • 2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID
  • tributylstannanyl
  • Thalidomide
  • Pranlukast
  • Triflusal
BTRC and NFKB1 beta-transducin repeat containing E3 ubiquitin protein ligase nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
  • Signaling by the B Cell Receptor (BCR)
  • Hedgehog 'off' state
  • misspliced GSK3beta mutants stabilize beta-catenin
  • T41 mutants of beta-catenin aren't phosphorylated
  • TCF7L2 mutants don't bind CTBP
  • truncated APC mutants destabilize the destruction complex
  • Signaling by Wnt
  • Regulation of PLK1 Activity at G2/M Transition
  • Downstream signaling events of B Cell Receptor (BCR)
  • Degradation of beta-catenin by the destruction complex
  • AXIN mutants destabilize the destruction complex, activating WNT signaling
  • S33 mutants of beta-catenin aren't phosphorylated
  • RNF mutants show enhanced WNT signaling and proliferation
  • Prolactin receptor signaling
  • truncations of AMER1 destabilize the destruction complex
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex
  • Host Interactions of HIV factors
  • AXIN missense mutants destabilize the destruction complex
  • S45 mutants of beta-catenin aren't phosphorylated
  • Regulation of APC/C activators between G1/S and early anaphase
  • Signaling by ERBB4
  • APC/C-mediated degradation of cell cycle proteins
  • Signaling by Interleukins
  • deletions in the AMER1 gene destabilize the destruction complex
  • AMER1 mutants destabilize the destruction complex
  • Interleukin-1 signaling
  • Mitotic G2-G2/M phases
  • Adaptive Immune System
  • Antigen processing: Ubiquitination & Proteasome degradation
  • APC truncation mutants have impaired AXIN binding
  • HIV Infection
  • G2/M Transition
  • deactivation of the beta-catenin transactivating complex
  • APC truncation mutants are not K63 polyubiquitinated
  • S37 mutants of beta-catenin aren't phosphorylated
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • Class I MHC mediated antigen processing & presentation
  • Vpu mediated degradation of CD4
  • Cytokine Signaling in Immune system
  • Cell Cycle, Mitotic
  • Nuclear signaling by ERBB4
  • TCF dependent signaling in response to WNT
  • Activation of NF-kappaB in B cells
  • SCF-beta-TrCP mediated degradation of Emi1
  • Regulation of mitotic cell cycle
  • deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling
  • Signaling by Hedgehog
  • Degradation of GLI1 by the proteasome
  • Signaling by WNT in cancer
  • GLI3 is processed to GLI3R by the proteasome
  • Degradation of GLI2 by the proteasome
  • Signaling by the B Cell Receptor (BCR)
  • NF-kB is activated and signals survival
  • Downstream TCR signaling
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Cellular Senescence
  • RIP-mediated NFkB activation via ZBP1
  • Toll Like Receptor TLR6:TLR2 Cascade
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • Activated TLR4 signalling
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Downstream signaling events of B Cell Receptor (BCR)
  • FCERI mediated NF-kB activation
  • MyD88 cascade initiated on plasma membrane
  • Toll Like Receptor 5 (TLR5) Cascade
  • ZBP1(DAI) mediated induction of type I IFNs
  • p75NTR signals via NF-kB
  • Transcriptional regulation of white adipocyte differentiation
  • MyD88 dependent cascade initiated on endosome
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • MyD88:Mal cascade initiated on plasma membrane
  • Toll Like Receptor 9 (TLR9) Cascade
  • Innate Immune System
  • Regulated proteolysis of p75NTR
  • Signalling by NGF
  • TRIF-mediated TLR3/TLR4 signaling
  • Cytosolic sensors of pathogen-associated DNA
  • Senescence-Associated Secretory Phenotype (SASP)
  • Cytokine Signaling in Immune system
  • p75 NTR receptor-mediated signalling
  • MyD88-independent cascade
  • Toll Like Receptor 2 (TLR2) Cascade
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Signaling by Interleukins
  • TCR signaling
  • Toll-Like Receptors Cascades
  • Toll Like Receptor 10 (TLR10) Cascade
  • Interleukin-1 processing
  • Toll Like Receptor 3 (TLR3) Cascade
  • Toll Like Receptor 4 (TLR4) Cascade
  • Activation of NF-kappaB in B cells
  • Fc epsilon receptor (FCERI) signaling
  • TRAF6 mediated NF-kB activation
  • Interleukin-1 signaling
  • Adaptive Immune System
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Thalidomide
  • Pranlukast
  • Triflusal
RXRA and HDAC4 retinoid X receptor, alpha histone deacetylase 4
  • Bile acid and bile salt metabolism
  • Metabolism of lipids and lipoproteins
  • Nuclear Receptor transcription pathway
  • Metabolic disorders of biological oxidation enzymes
  • Defective CYP2U1 causes Spastic paraplegia 56, autosomal recessive (SPG56)
  • Generic Transcription Pathway
  • Endogenous sterols
  • Synthesis of bile acids and bile salts
  • Orphan transporters
  • Defective FMO3 causes Trimethylaminuria (TMAU)
  • Signaling by Retinoic Acid
  • Recycling of bile acids and salts
  • Defective CYP26B1 causes Radiohumeral fusions with other skeletal and craniofacial anomalies (RHFCA)
  • Defective CYP17A1 causes Adrenal hyperplasia 5 (AH5)
  • Defective CYP19A1 causes Aromatase excess syndrome (AEXS)
  • Regulation of pyruvate dehydrogenase (PDH) complex
  • Pyruvate metabolism
  • Synthesis of bile acids and bile salts via 27-hydroxycholesterol
  • Defective MAOA causes Brunner syndrome (BRUNS)
  • Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3)
  • Activation of gene expression by SREBF (SREBP)
  • The citric acid (TCA) cycle and respiratory electron transport
  • Transcriptional activation of mitochondrial biogenesis
  • PPARA activates gene expression
  • Defective CYP2R1 causes Rickets vitamin D-dependent 1B (VDDR1B)
  • Organelle biogenesis and maintenance
  • Import of palmitoyl-CoA into the mitochondrial matrix
  • Pyruvate metabolism and Citric Acid (TCA) cycle
  • Defective CYP27B1 causes Rickets vitamin D-dependent 1A (VDDR1A)
  • Phase 1 - Functionalization of compounds
  • RORA activates circadian gene expression
  • Regulation of cholesterol biosynthesis by SREBP (SREBF)
  • Defective CYP26C1 causes Focal facial dermal dysplasia 4 (FFDD4)
  • Cytochrome P450 - arranged by substrate type
  • Transcriptional regulation of white adipocyte differentiation
  • Biological oxidations
  • Defective TBXAS1 causes Ghosal hematodiaphyseal dysplasia (GHDD)
  • Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)
  • Fatty acid, triacylglycerol, and ketone body metabolism
  • Defective CYP27A1 causes Cerebrotendinous xanthomatosis (CTX)
  • Defective CYP11B1 causes Adrenal hyperplasia 4 (AH4)
  • REV-ERBA represses gene expression
  • Defective CYP1B1 causes Glaucoma
  • Mitochondrial biogenesis
  • Defective CYP7B1 causes Spastic paraplegia 5A, autosomal recessive (SPG5A) and Congenital bile acid synthesis defect 3 (CBAS3)
  • Defective CYP4F22 causes Ichthyosis, congenital, autosomal recessive 5 (ARCI5)
  • Defective CYP24A1 causes Hypercalcemia, infantile (HCAI)
  • Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol
  • Defective CYP11B2 causes Corticosterone methyloxidase 1 deficiency (CMO-1 deficiency)
  • YAP1- and WWTR1 (TAZ)-stimulated gene expression
  • Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
  • BMAL1:CLOCK,NPAS2 activates circadian gene expression
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • Signaling by NOTCH
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Signaling by NOTCH1
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • Signaling by NOTCH1 in Cancer
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • FBXW7 Mutants and NOTCH1 in Cancer
  • Adapalene
  • Bexarotene
  • Acitretin
  • Alitretinoin
  • Etodolac
  • Etretinate
  • (5BETA)-PREGNANE-3,20-DIONE
  • 2-chloro-5-nitro-N-phenylbenzamide
  • 1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE
  • 2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID
  • tributylstannanyl
RXRA and ARNTL retinoid X receptor, alpha aryl hydrocarbon receptor nuclear translocator-like
  • Bile acid and bile salt metabolism
  • Metabolism of lipids and lipoproteins
  • Nuclear Receptor transcription pathway
  • Metabolic disorders of biological oxidation enzymes
  • Defective CYP2U1 causes Spastic paraplegia 56, autosomal recessive (SPG56)
  • Generic Transcription Pathway
  • Endogenous sterols
  • Synthesis of bile acids and bile salts
  • Orphan transporters
  • Defective FMO3 causes Trimethylaminuria (TMAU)
  • Signaling by Retinoic Acid
  • Recycling of bile acids and salts
  • Defective CYP26B1 causes Radiohumeral fusions with other skeletal and craniofacial anomalies (RHFCA)
  • Defective CYP17A1 causes Adrenal hyperplasia 5 (AH5)
  • Defective CYP19A1 causes Aromatase excess syndrome (AEXS)
  • Regulation of pyruvate dehydrogenase (PDH) complex
  • Pyruvate metabolism
  • Synthesis of bile acids and bile salts via 27-hydroxycholesterol
  • Defective MAOA causes Brunner syndrome (BRUNS)
  • Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3)
  • Activation of gene expression by SREBF (SREBP)
  • The citric acid (TCA) cycle and respiratory electron transport
  • Transcriptional activation of mitochondrial biogenesis
  • PPARA activates gene expression
  • Defective CYP2R1 causes Rickets vitamin D-dependent 1B (VDDR1B)
  • Organelle biogenesis and maintenance
  • Import of palmitoyl-CoA into the mitochondrial matrix
  • Pyruvate metabolism and Citric Acid (TCA) cycle
  • Defective CYP27B1 causes Rickets vitamin D-dependent 1A (VDDR1A)
  • Phase 1 - Functionalization of compounds
  • RORA activates circadian gene expression
  • Regulation of cholesterol biosynthesis by SREBP (SREBF)
  • Defective CYP26C1 causes Focal facial dermal dysplasia 4 (FFDD4)
  • Cytochrome P450 - arranged by substrate type
  • Transcriptional regulation of white adipocyte differentiation
  • Biological oxidations
  • Defective TBXAS1 causes Ghosal hematodiaphyseal dysplasia (GHDD)
  • Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)
  • Fatty acid, triacylglycerol, and ketone body metabolism
  • Defective CYP27A1 causes Cerebrotendinous xanthomatosis (CTX)
  • Defective CYP11B1 causes Adrenal hyperplasia 4 (AH4)
  • REV-ERBA represses gene expression
  • Defective CYP1B1 causes Glaucoma
  • Mitochondrial biogenesis
  • Defective CYP7B1 causes Spastic paraplegia 5A, autosomal recessive (SPG5A) and Congenital bile acid synthesis defect 3 (CBAS3)
  • Defective CYP4F22 causes Ichthyosis, congenital, autosomal recessive 5 (ARCI5)
  • Defective CYP24A1 causes Hypercalcemia, infantile (HCAI)
  • Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol
  • Defective CYP11B2 causes Corticosterone methyloxidase 1 deficiency (CMO-1 deficiency)
  • YAP1- and WWTR1 (TAZ)-stimulated gene expression
  • Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
  • BMAL1:CLOCK,NPAS2 activates circadian gene expression
  • PPARA activates gene expression
  • Fatty acid, triacylglycerol, and ketone body metabolism
  • Metabolism of lipids and lipoproteins
  • Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
  • REV-ERBA represses gene expression
  • BMAL1:CLOCK,NPAS2 activates circadian gene expression
  • RORA activates circadian gene expression
  • Adapalene
  • Bexarotene
  • Acitretin
  • Alitretinoin
  • Etodolac
  • Etretinate
  • (5BETA)-PREGNANE-3,20-DIONE
  • 2-chloro-5-nitro-N-phenylbenzamide
  • 1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE
  • 2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID
  • tributylstannanyl
RAC1 and ARHGAP31 ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) Rho GTPase activating protein 31
  • Signaling by GPCR
  • DCC mediated attractive signaling
  • FCERI mediated MAPK activation
  • Signaling by Wnt
  • Nef and signal transduction
  • Signaling by SCF-KIT
  • DAP12 signaling
  • EPH-Ephrin signaling
  • Fcgamma receptor (FCGR) dependent phagocytosis
  • Regulation of actin dynamics for phagocytic cup formation
  • Sema4D induced cell migration and growth-cone collapse
  • DAP12 interactions
  • Host Interactions of HIV factors
  • CD28 co-stimulation
  • The role of Nef in HIV-1 replication and disease pathogenesis
  • Factors involved in megakaryocyte development and platelet production
  • GPCR downstream signaling
  • Signaling by VEGF
  • Fc epsilon receptor (FCERI) signaling
  • Sema3A PAK dependent Axon repulsion
  • SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
  • Platelet activation, signaling and aggregation
  • PCP/CE pathway
  • Adaptive Immune System
  • Axon guidance
  • Costimulation by the CD28 family
  • HIV Infection
  • Translocation of GLUT4 to the plasma membrane
  • L1CAM interactions
  • VEGFA-VEGFR2 Pathway
  • EPHB-mediated forward signaling
  • Inactivation of Cdc42 and Rac
  • Ephrin signaling
  • EPH-ephrin mediated repulsion of cells
  • Activation of Rac
  • VEGFR2 mediated vascular permeability
  • Sema4D mediated inhibition of cell attachment and migration
  • G alpha (12/13) signalling events
  • Sema4D in semaphorin signaling
  • Netrin-1 signaling
  • Innate Immune System
  • Signalling by NGF
  • Signal transduction by L1
  • Cell death signalling via NRAGE, NRIF and NADE
  • Semaphorin interactions
  • p75 NTR receptor-mediated signalling
  • beta-catenin independent WNT signaling
  • CD28 dependent Vav1 pathway
  • DSCAM interactions
  • NRAGE signals death through JNK
  • GPVI-mediated activation cascade
  • Signaling by Robo receptor
  • Rho GTPase cycle
  • Signaling by Rho GTPases
  • Guanosine-5\'-Diphosphate
ITPR1 and BANK1 inositol 1,4,5-trisphosphate receptor, type 1 B-cell scaffold protein with ankyrin repeats 1
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by GPCR
  • Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
  • Phospholipase C-mediated cascade
  • Signaling by FGFR in disease
  • Integration of energy metabolism
  • cGMP effects
  • Signaling by Wnt
  • Signaling by EGFRvIII in Cancer
  • PLCG1 events in ERBB2 signaling
  • Effects of PIP2 hydrolysis
  • Platelet calcium homeostasis
  • DAP12 signaling
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Role of phospholipids in phagocytosis
  • Fcgamma receptor (FCGR) dependent phagocytosis
  • Signaling by PDGF
  • DAP12 interactions
  • Opioid Signalling
  • EGFR interacts with phospholipase C-gamma
  • Signaling by ERBB2
  • G alpha (q) signalling events
  • Signaling by EGFR
  • GPCR downstream signaling
  • Platelet homeostasis
  • Signaling by VEGF
  • Downstream signal transduction
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • Platelet activation, signaling and aggregation
  • Adaptive Immune System
  • G alpha (q) signalling events
  • DAG and IP3 signaling
  • VEGFA-VEGFR2 Pathway
  • VEGFR2 mediated cell proliferation
  • Downstream signaling of activated FGFR
  • Nitric oxide stimulates guanylate cyclase
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Innate Immune System
  • Signalling by NGF
  • PLC beta mediated events
  • Regulation of insulin secretion
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • G-protein mediated events
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • beta-catenin independent WNT signaling
  • Signaling by FGFR
  • Ca2+ pathway
  • Elevation of cytosolic Ca2+ levels
  • PLC-gamma1 signalling
  • FCERI mediated Ca+2 mobilization
RAC1 and PPP2R2B ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) protein phosphatase 2, regulatory subunit B, beta
  • Signaling by GPCR
  • DCC mediated attractive signaling
  • FCERI mediated MAPK activation
  • Signaling by Wnt
  • Nef and signal transduction
  • Signaling by SCF-KIT
  • DAP12 signaling
  • EPH-Ephrin signaling
  • Fcgamma receptor (FCGR) dependent phagocytosis
  • Regulation of actin dynamics for phagocytic cup formation
  • Sema4D induced cell migration and growth-cone collapse
  • DAP12 interactions
  • Host Interactions of HIV factors
  • CD28 co-stimulation
  • The role of Nef in HIV-1 replication and disease pathogenesis
  • Factors involved in megakaryocyte development and platelet production
  • GPCR downstream signaling
  • Signaling by VEGF
  • Fc epsilon receptor (FCERI) signaling
  • Sema3A PAK dependent Axon repulsion
  • SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
  • Platelet activation, signaling and aggregation
  • PCP/CE pathway
  • Adaptive Immune System
  • Axon guidance
  • Costimulation by the CD28 family
  • HIV Infection
  • Translocation of GLUT4 to the plasma membrane
  • L1CAM interactions
  • VEGFA-VEGFR2 Pathway
  • EPHB-mediated forward signaling
  • Inactivation of Cdc42 and Rac
  • Ephrin signaling
  • EPH-ephrin mediated repulsion of cells
  • Activation of Rac
  • VEGFR2 mediated vascular permeability
  • Sema4D mediated inhibition of cell attachment and migration
  • G alpha (12/13) signalling events
  • Sema4D in semaphorin signaling
  • Netrin-1 signaling
  • Innate Immune System
  • Signalling by NGF
  • Signal transduction by L1
  • Cell death signalling via NRAGE, NRIF and NADE
  • Semaphorin interactions
  • p75 NTR receptor-mediated signalling
  • beta-catenin independent WNT signaling
  • CD28 dependent Vav1 pathway
  • DSCAM interactions
  • NRAGE signals death through JNK
  • GPVI-mediated activation cascade
  • Signaling by Robo receptor
  • Guanosine-5\'-Diphosphate
RAC1 and BAG6 ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) BCL2-associated athanogene 6
  • Signaling by GPCR
  • DCC mediated attractive signaling
  • FCERI mediated MAPK activation
  • Signaling by Wnt
  • Nef and signal transduction
  • Signaling by SCF-KIT
  • DAP12 signaling
  • EPH-Ephrin signaling
  • Fcgamma receptor (FCGR) dependent phagocytosis
  • Regulation of actin dynamics for phagocytic cup formation
  • Sema4D induced cell migration and growth-cone collapse
  • DAP12 interactions
  • Host Interactions of HIV factors
  • CD28 co-stimulation
  • The role of Nef in HIV-1 replication and disease pathogenesis
  • Factors involved in megakaryocyte development and platelet production
  • GPCR downstream signaling
  • Signaling by VEGF
  • Fc epsilon receptor (FCERI) signaling
  • Sema3A PAK dependent Axon repulsion
  • SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
  • Platelet activation, signaling and aggregation
  • PCP/CE pathway
  • Adaptive Immune System
  • Axon guidance
  • Costimulation by the CD28 family
  • HIV Infection
  • Translocation of GLUT4 to the plasma membrane
  • L1CAM interactions
  • VEGFA-VEGFR2 Pathway
  • EPHB-mediated forward signaling
  • Inactivation of Cdc42 and Rac
  • Ephrin signaling
  • EPH-ephrin mediated repulsion of cells
  • Activation of Rac
  • VEGFR2 mediated vascular permeability
  • Sema4D mediated inhibition of cell attachment and migration
  • G alpha (12/13) signalling events
  • Sema4D in semaphorin signaling
  • Netrin-1 signaling
  • Innate Immune System
  • Signalling by NGF
  • Signal transduction by L1
  • Cell death signalling via NRAGE, NRIF and NADE
  • Semaphorin interactions
  • p75 NTR receptor-mediated signalling
  • beta-catenin independent WNT signaling
  • CD28 dependent Vav1 pathway
  • DSCAM interactions
  • NRAGE signals death through JNK
  • GPVI-mediated activation cascade
  • Signaling by Robo receptor
  • Guanosine-5\'-Diphosphate
CDK7 and CTDP1 cyclin-dependent kinase 7 CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) phosphatase, subunit 1
  • RNA Polymerase II Promoter Escape
  • Formation of HIV-1 elongation complex containing HIV-1 Tat
  • RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
  • RNA Polymerase I Chain Elongation
  • RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription
  • Tat-mediated elongation of the HIV-1 transcript
  • Cyclin E associated events during G1/S transition
  • Formation of transcription-coupled NER (TC-NER) repair complex
  • Dual incision reaction in TC-NER
  • NoRC negatively regulates rRNA expression
  • G1/S Transition
  • Mitotic G1-G1/S phases
  • S Phase
  • Late Phase of HIV Life Cycle
  • Formation of RNA Pol II elongation complex
  • Global Genomic NER (GG-NER)
  • RNA Polymerase II Transcription Initiation And Promoter Clearance
  • Cyclin A:Cdk2-associated events at S phase entry
  • Mitotic G2-G2/M phases
  • Transcription of the HIV genome
  • Nucleotide Excision Repair
  • RNA Polymerase II Transcription
  • RNA Polymerase I Transcription Initiation
  • HIV Infection
  • RNA Polymerase I Promoter Clearance
  • Formation of the Early Elongation Complex
  • G2/M Transition
  • RNA Pol II CTD phosphorylation and interaction with CE
  • RNA Polymerase II Pre-transcription Events
  • HIV Transcription Initiation
  • HIV Life Cycle
  • RNA Pol II CTD phosphorylation and interaction with CE
  • Cyclin A/B1 associated events during G2/M transition
  • RNA Polymerase II HIV Promoter Escape
  • HIV Transcription Elongation
  • Dual incision reaction in GG-NER
  • RNA Polymerase I Transcription
  • mRNA Capping
  • RNA Polymerase I Promoter Escape
  • RNA Polymerase I Transcription Termination
  • G1 Phase
  • Epigenetic regulation of gene expression
  • Negative epigenetic regulation of rRNA expression
  • Cell Cycle, Mitotic
  • Cyclin D associated events in G1
  • Transcription-coupled NER (TC-NER)
  • Formation of HIV elongation complex in the absence of HIV Tat
  • Formation of the HIV-1 Early Elongation Complex
  • Formation of incision complex in GG-NER
  • RNA Polymerase II Transcription Initiation
  • RNA Polymerase II Transcription Elongation
  • Formation of HIV-1 elongation complex containing HIV-1 Tat
  • RNA Polymerase II Transcription
  • Abortive elongation of HIV-1 transcript in the absence of Tat
  • HIV Infection
  • Formation of the Early Elongation Complex
  • Tat-mediated elongation of the HIV-1 transcript
  • Tat-mediated HIV elongation arrest and recovery
  • RNA Polymerase II Pre-transcription Events
  • Late Phase of HIV Life Cycle
  • Pausing and recovery of Tat-mediated HIV elongation
  • Formation of RNA Pol II elongation complex
  • HIV elongation arrest and recovery
  • HIV Life Cycle
  • Pausing and recovery of HIV elongation
  • Formation of HIV elongation complex in the absence of HIV Tat
  • Formation of the HIV-1 Early Elongation Complex
  • HIV Transcription Elongation
  • Transcription of the HIV genome
  • RNA Polymerase II Transcription Elongation
  • Phosphonothreonine
  • Flavopiridol
CDK7 and HLA-DQA1 cyclin-dependent kinase 7 major histocompatibility complex, class II, DQ alpha 1
  • RNA Polymerase II Promoter Escape
  • Formation of HIV-1 elongation complex containing HIV-1 Tat
  • RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
  • RNA Polymerase I Chain Elongation
  • RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription
  • Tat-mediated elongation of the HIV-1 transcript
  • Cyclin E associated events during G1/S transition
  • Formation of transcription-coupled NER (TC-NER) repair complex
  • Dual incision reaction in TC-NER
  • NoRC negatively regulates rRNA expression
  • G1/S Transition
  • Mitotic G1-G1/S phases
  • S Phase
  • Late Phase of HIV Life Cycle
  • Formation of RNA Pol II elongation complex
  • Global Genomic NER (GG-NER)
  • RNA Polymerase II Transcription Initiation And Promoter Clearance
  • Cyclin A:Cdk2-associated events at S phase entry
  • Mitotic G2-G2/M phases
  • Transcription of the HIV genome
  • Nucleotide Excision Repair
  • RNA Polymerase II Transcription
  • RNA Polymerase I Transcription Initiation
  • HIV Infection
  • RNA Polymerase I Promoter Clearance
  • Formation of the Early Elongation Complex
  • G2/M Transition
  • RNA Pol II CTD phosphorylation and interaction with CE
  • RNA Polymerase II Pre-transcription Events
  • HIV Transcription Initiation
  • HIV Life Cycle
  • RNA Pol II CTD phosphorylation and interaction with CE
  • Cyclin A/B1 associated events during G2/M transition
  • RNA Polymerase II HIV Promoter Escape
  • HIV Transcription Elongation
  • Dual incision reaction in GG-NER
  • RNA Polymerase I Transcription
  • mRNA Capping
  • RNA Polymerase I Promoter Escape
  • RNA Polymerase I Transcription Termination
  • G1 Phase
  • Epigenetic regulation of gene expression
  • Negative epigenetic regulation of rRNA expression
  • Cell Cycle, Mitotic
  • Cyclin D associated events in G1
  • Transcription-coupled NER (TC-NER)
  • Formation of HIV elongation complex in the absence of HIV Tat
  • Formation of the HIV-1 Early Elongation Complex
  • Formation of incision complex in GG-NER
  • RNA Polymerase II Transcription Initiation
  • RNA Polymerase II Transcription Elongation
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Phosphonothreonine
  • Flavopiridol
FGF7 and NRP1 fibroblast growth factor 7 neuropilin 1
  • Signaling by the B Cell Receptor (BCR)
  • Phospholipase C-mediated cascade
  • Signaling by FGFR in disease
  • SHC-mediated cascade
  • Signaling by EGFRvIII in Cancer
  • Signaling by SCF-KIT
  • Signaling by FGFR2 mutants
  • DAP12 signaling
  • Downstream signaling events of B Cell Receptor (BCR)
  • PI3K/AKT activation
  • PI-3K cascade
  • PI3K Cascade
  • Negative regulation of FGFR signaling
  • Signaling by PDGF
  • DAP12 interactions
  • GAB1 signalosome
  • Signaling by ERBB4
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • Constitutive PI3K/AKT Signaling in Cancer
  • Activated point mutants of FGFR2
  • PI3K events in ERBB4 signaling
  • Signaling by ERBB2
  • Signaling by EGFR
  • Downstream signal transduction
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by FGFR mutants
  • Signaling by EGFR in Cancer
  • PI3K/AKT Signaling in Cancer
  • Adaptive Immune System
  • IRS-mediated signalling
  • PIP3 activates AKT signaling
  • IGF1R signaling cascade
  • IRS-related events triggered by IGF1R
  • PI3K events in ERBB2 signaling
  • Downstream signaling of activated FGFR
  • FGFR ligand binding and activation
  • FGFR2b ligand binding and activation
  • Signaling by Insulin receptor
  • Innate Immune System
  • Signalling by NGF
  • Insulin receptor signalling cascade
  • IRS-related events
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Signaling by FGFR
  • IRS-mediated signalling
  • FGFR2 ligand binding and activation
  • FRS2-mediated cascade
  • Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
  • PI3K Cascade
  • Signal transduction by L1
  • CHL1 interactions
  • Axon guidance
  • Semaphorin interactions
  • Signaling by VEGF
  • Sema3A PAK dependent Axon repulsion
  • Neurophilin interactions with VEGF and VEGFR
  • L1CAM interactions
  • SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
  • CRMPs in Sema3A signaling
MNAT1 and TRIM26 MNAT CDK-activating kinase assembly factor 1 tripartite motif containing 26
  • RNA Polymerase II Promoter Escape
  • Formation of HIV-1 elongation complex containing HIV-1 Tat
  • RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
  • RNA Polymerase I Chain Elongation
  • RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription
  • Tat-mediated elongation of the HIV-1 transcript
  • Cyclin E associated events during G1/S transition
  • Formation of transcription-coupled NER (TC-NER) repair complex
  • Dual incision reaction in TC-NER
  • NoRC negatively regulates rRNA expression
  • G1/S Transition
  • Mitotic G1-G1/S phases
  • S Phase
  • Late Phase of HIV Life Cycle
  • Formation of RNA Pol II elongation complex
  • Global Genomic NER (GG-NER)
  • RNA Polymerase II Transcription Initiation And Promoter Clearance
  • Cyclin A:Cdk2-associated events at S phase entry
  • Mitotic G2-G2/M phases
  • Transcription of the HIV genome
  • Nucleotide Excision Repair
  • RNA Polymerase II Transcription
  • RNA Polymerase I Transcription Initiation
  • HIV Infection
  • RNA Polymerase I Promoter Clearance
  • Formation of the Early Elongation Complex
  • G2/M Transition
  • RNA Pol II CTD phosphorylation and interaction with CE
  • RNA Polymerase II Pre-transcription Events
  • HIV Transcription Initiation
  • HIV Life Cycle
  • RNA Pol II CTD phosphorylation and interaction with CE
  • Cyclin A/B1 associated events during G2/M transition
  • RNA Polymerase II HIV Promoter Escape
  • HIV Transcription Elongation
  • Dual incision reaction in GG-NER
  • RNA Polymerase I Transcription
  • mRNA Capping
  • RNA Polymerase I Promoter Escape
  • RNA Polymerase I Transcription Termination
  • G1 Phase
  • Epigenetic regulation of gene expression
  • Negative epigenetic regulation of rRNA expression
  • Cell Cycle, Mitotic
  • Cyclin D associated events in G1
  • Transcription-coupled NER (TC-NER)
  • Formation of HIV elongation complex in the absence of HIV Tat
  • Formation of the HIV-1 Early Elongation Complex
  • Formation of incision complex in GG-NER
  • RNA Polymerase II Transcription Initiation
  • RNA Polymerase II Transcription Elongation
  • Interferon gamma signaling
  • Interferon Signaling
  • Cytokine Signaling in Immune system
CCNH and CTD cyclin H Coats disease
  • RNA Polymerase II Promoter Escape
  • Formation of HIV-1 elongation complex containing HIV-1 Tat
  • RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
  • RNA Polymerase I Chain Elongation
  • RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription
  • Tat-mediated elongation of the HIV-1 transcript
  • Cyclin E associated events during G1/S transition
  • Formation of transcription-coupled NER (TC-NER) repair complex
  • Dual incision reaction in TC-NER
  • NoRC negatively regulates rRNA expression
  • G1/S Transition
  • Mitotic G1-G1/S phases
  • S Phase
  • Late Phase of HIV Life Cycle
  • Formation of RNA Pol II elongation complex
  • Global Genomic NER (GG-NER)
  • RNA Polymerase II Transcription Initiation And Promoter Clearance
  • Cyclin A:Cdk2-associated events at S phase entry
  • Mitotic G2-G2/M phases
  • Transcription of the HIV genome
  • Nucleotide Excision Repair
  • RNA Polymerase II Transcription
  • RNA Polymerase I Transcription Initiation
  • HIV Infection
  • RNA Polymerase I Promoter Clearance
  • Formation of the Early Elongation Complex
  • G2/M Transition
  • RNA Pol II CTD phosphorylation and interaction with CE
  • RNA Polymerase II Pre-transcription Events
  • HIV Transcription Initiation
  • HIV Life Cycle
  • RNA Pol II CTD phosphorylation and interaction with CE
  • Cyclin A/B1 associated events during G2/M transition
  • RNA Polymerase II HIV Promoter Escape
  • HIV Transcription Elongation
  • Dual incision reaction in GG-NER
  • RNA Polymerase I Transcription
  • mRNA Capping
  • RNA Polymerase I Promoter Escape
  • RNA Polymerase I Transcription Termination
  • G1 Phase
  • Epigenetic regulation of gene expression
  • Negative epigenetic regulation of rRNA expression
  • Cell Cycle, Mitotic
  • Cyclin D associated events in G1
  • Transcription-coupled NER (TC-NER)
  • Formation of HIV elongation complex in the absence of HIV Tat
  • Formation of the HIV-1 Early Elongation Complex
  • Formation of incision complex in GG-NER
  • RNA Polymerase II Transcription Initiation
  • RNA Polymerase II Transcription Elongation
CDK7 and CTD cyclin-dependent kinase 7 Coats disease
  • RNA Polymerase II Promoter Escape
  • Formation of HIV-1 elongation complex containing HIV-1 Tat
  • RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
  • RNA Polymerase I Chain Elongation
  • RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription
  • Tat-mediated elongation of the HIV-1 transcript
  • Cyclin E associated events during G1/S transition
  • Formation of transcription-coupled NER (TC-NER) repair complex
  • Dual incision reaction in TC-NER
  • NoRC negatively regulates rRNA expression
  • G1/S Transition
  • Mitotic G1-G1/S phases
  • S Phase
  • Late Phase of HIV Life Cycle
  • Formation of RNA Pol II elongation complex
  • Global Genomic NER (GG-NER)
  • RNA Polymerase II Transcription Initiation And Promoter Clearance
  • Cyclin A:Cdk2-associated events at S phase entry
  • Mitotic G2-G2/M phases
  • Transcription of the HIV genome
  • Nucleotide Excision Repair
  • RNA Polymerase II Transcription
  • RNA Polymerase I Transcription Initiation
  • HIV Infection
  • RNA Polymerase I Promoter Clearance
  • Formation of the Early Elongation Complex
  • G2/M Transition
  • RNA Pol II CTD phosphorylation and interaction with CE
  • RNA Polymerase II Pre-transcription Events
  • HIV Transcription Initiation
  • HIV Life Cycle
  • RNA Pol II CTD phosphorylation and interaction with CE
  • Cyclin A/B1 associated events during G2/M transition
  • RNA Polymerase II HIV Promoter Escape
  • HIV Transcription Elongation
  • Dual incision reaction in GG-NER
  • RNA Polymerase I Transcription
  • mRNA Capping
  • RNA Polymerase I Promoter Escape
  • RNA Polymerase I Transcription Termination
  • G1 Phase
  • Epigenetic regulation of gene expression
  • Negative epigenetic regulation of rRNA expression
  • Cell Cycle, Mitotic
  • Cyclin D associated events in G1
  • Transcription-coupled NER (TC-NER)
  • Formation of HIV elongation complex in the absence of HIV Tat
  • Formation of the HIV-1 Early Elongation Complex
  • Formation of incision complex in GG-NER
  • RNA Polymerase II Transcription Initiation
  • RNA Polymerase II Transcription Elongation
  • Phosphonothreonine
  • Flavopiridol

Page 4 out of 82 pages